View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B8 CITIGROUP INC
-
U.S. Bank (USB) appoints Jay Martin to lead united Investment Services division
-
U.S. Bank Announces Leader for Investment Services Division
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form ATS-N/UA CITIGROUP GLOBAL MARKETS
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share
-
Nomura Capital Management Hires Ashu Pal as Head of Portfolio Management
-
North American Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share
-
US Financial 15 Split Corp. Preferred Dividend Declared
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citi Upgrades Fidelity National Information Services (FIS) to Buy
-
Form 424B8 CITIGROUP INC
-
Rithm Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 21, 2025
-
2 U.S. transportation stocks to avoid amid tariff risks: Citi
-
Form 424B8 CITIGROUP INC
-
Citi Reiterates Buy Rating on Charles Schwab Corp. (SCHW)
-
Citi Reiterates Neutral Rating on American Express (AXP)
-
Citi Reiterates Neutral Rating on Netflix (NFLX)
-
Citizens JMP Reiterates Market Outperform Rating on Werewolf Therapeutics Inc. (HOWL)
-
Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
-
Citizens JMP Reiterates Market Outperform Rating on Prelude Therapeutics (PRLD)
-
Citizens JMP Reiterates Market Outperform Rating on Cue Biopharma (CUE)
-
Citizens JMP Reiterates Market Outperform Rating on Blueprint Medicines (BPMC)
-
Citizens JMP Reiterates Market Outperform Rating on BioAtla Inc. (BCAB)
-
Citizens JMP Reiterates Market Perform Rating on Adicet Bio Inc. (ACET)

